1. Alatab S, Sepanlou SG, Ikuta K, et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2020;5:17–30.

2. Kim ES, Kim WH. Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics. Gut Liver 2010;4:1–14.

3. Ng WK, Wong SH, Ng SC. Changing epidemiological trends of inflammatory bowel disease in Asia. Intest Res 2016;14:111–119.

4. Kaibullayeva J, Ualiyeva A, Oshibayeva A, Dushpanova A, Marshall JK. Prevalence and patient awareness of inflammatory bowel disease in Kazakhstan: a cross-sectional study. Intest Res 2020;18:430–437.

5. Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol 2014;20:91–99.

6. Owczarek D, Rodacki T, Domagała-Rodacka R, Cibor D, Mach T. Diet and nutritional factors in inflammatory bowel diseases. World J Gastroenterol 2016;22:895–905.

7. Cohen AB, Lee D, Long MD, et al. Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci 2013;58:1322–1328.

8. Yoon JY. Nutritional approach as therapeutic manipulation in inflammatory bowel disease. Intest Res 2019;17:463–475.

9. Shafiee NH, Manaf ZA, Mokhtar NM, Raja Ali RA. An assessment of dietary intake, food avoidance and food beliefs in patients with ulcerative colitis of different disease status. Intest Res 2020;18:447–458.

10. Ko KH, Kim YS, Lee BK, et al. Vitamin D deficiency is associated with disease activity in patients with Crohn’s disease. Intest Res 2019;17:70–77.

11. Green N, Miller T, Suskind D, Lee D. A review of dietary therapy for IBD and a vision for the future. Nutrients 2019;11:947.

12. Mentella MC, Scaldaferri F, Pizzoferrato M, Gasbarrini A, Miggiano GA. Nutrition, IBD and gut microbiota: a review. Nutrients 2020;12:944.

13. Kim SE. Nutritional screening and assessment in hospitalized patients. Korean J Gastroenterol 2015;65:336–341.

14. Antonio J, Kenyon M, Ellerbroek A, et al. Body composition assessment: a comparison of the bod pod, InBody 770, and DXA. J Exerc Nutr 2019;2:11. 15. Marra M, Sammarco R, De Lorenzo A, et al. Assessment of body composition in health and disease using bioelectrical impedance analysis (BIA) and dual energy X-ray absorptiometry (DXA): a critical overview. Contrast Media Mol Imaging 2019;2019:3548284.

16. Bhattacharya A, Pal B, Mukherjee S, Roy SK. Assessment of nutritional status using anthropometric variables by multivariate analysis. BMC Public Health 2019;19:1045.

17. Krel C, Piko N, Tomazic J, Bevc S. Bioelectrical impedance analysis as a marker of nutritional status in chronically ill patients. Aust J Adv Nurs 2019;36:14–21. 18. Bryant RV, Trott MJ, Bartholomeusz FD, Andrews JM. Systematic review: body composition in adults with inflammatory bowel disease. Aliment Pharmacol Ther 2013;38:213–225.

19. Zalizko P, Roshofa TH, Meija L, Bodnieks E, Pukitis A. The role of body muscle mass as an indicator of activity in inflammatory bowel disease patients. Clin Nutr ESPEN 2020;40:193–200.

20. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study. N Engl J Med 1987;317:1625–1629.

21. Harvey RF, Bradshaw JM. A simple index of Crohn’s-disease activity. Lancet 1980;1:514.

22. Alhagamhmad MH, Day AS, Lemberg DA, Leach ST. An update of the role of nutritional therapy in the management of Crohn’s disease. J Gastroenterol 2012;47:872–882.

23. Cioffi I, Imperatore N, Di Vincenzo O, et al. Association between health-related quality of life and nutritional status in adult patients with Crohn’s disease. Nutrients 2020;12:746.

24. Mijac DD, Janković GL, Jorga J, Krstić MN. Nutritional status in patients with active inflammatory bowel disease: prevalence of malnutrition and methods for routine nutritional assessment. Eur J Intern Med 2010;21:315–319.

25. Kuchnia A, Earthman C, Teigen L, et al. Evaluation of bioelectrical impedance analysis in critically ill patients: results of a multicenter prospective study. JPEN J Parenter Enteral Nutr 2017;41:1131–1138.

26. Wilson FP, Xie D, Anderson AH, et al. Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC study. Clin J Am Soc Nephrol 2014;9:2095–2103.

27. Kaitha S, Bashir M, Ali T. Iron deficiency anemia in inflammatory bowel disease. World J Gastrointest Pathophysiol 2015;6:62–72.

28. Powell-Tuck J. Protein metabolism in inflammatory bowel disease. Gut 1986;27 Suppl 1(Suppl 1): 67–71.

29. Kelsen J, Baldassano RN. Inflammatory bowel disease: the difference between children and adults. Inflamm Bowel Dis 2008;14 Suppl 2:S9–S11.

30. Farthing M, Salam MA, Lindberg G, et al. Acute diarrhea in adults and children: a global perspective. J Clin Gastroenterol 2013;47:12–20.

31. Alkhouri RH, Hashmi H, Baker RD, Gelfond D, Baker SS. Vitamin and mineral status in patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2013;56:89–92.

32. Ohlund I, Hernell O, Hörnell A, Stenlund H, Lind T. BMI at 4 years of age is associated with previous and current protein intake and with paternal BMI. Eur J Clin Nutr 2010;64:138–145.

33. Bijelic R, Balaban J, Milicevic S. Correlation of the lipid profile, BMI and bone mineral density in postmenopausal women. Mater Sociomed 2016;28:412–415.

34. Maaser C, Sturm A, Vavricka SR, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis 2019;13:144–164.

35. Shiga H, Abe I, Onodera M, et al. Serum C-reactive protein and albumin are useful biomarkers for tight control management of Crohn’s disease in Japan. Sci Rep 2020;10:511.

36. Agouridis AP, Elisaf M, Milionis HJ. An overview of lipid abnormalities in patients with inflammatory bowel disease. Ann Gastroenterol 2011;24:181–187.